Global ADHD Therapeutics Market to Reach $4.2 Billion by 2015, According to ... Behavioral Health Central (blog) Shire Pharmaceuticals is the largest player in the ADHD market with its strong portfolio of drugs including Adderall XR, Vyvanse, Daytrana and Intuniv. ... and more » |
Global ADHD Therapeutics Market to Reach $4.2 Billion by 2015, According to ... PR Web (press release) Shire Pharmaceuticals is the largest player in the ADHD market with its strong portfolio of drugs including Adderall XR, Vyvanse, Daytrana and Intuniv. ... and more » |
Shire lifted by American take-up of ADHD drug Times Online Vyvanse became Shire Pharmaceuticals' bestselling drug this year, with first-quarter sales up by nearly a third on the same period last year, ... Shire beats forecasts as new drugs plug gap left by generic competition Telegraph.co.uk Shire's Newer Products Balance Adderall Generics Hemscott all 46 news articles » |
Actavis Loses to FDA in ADHD Drug Ruling Courthouse News Service Actavis Elizabeth LLC claimed that it should be able to sell its generic version of the ADHD drug, because Shire Pharmaceuticals' Vyvanse was not a "new ... and more » |